Platelet Aggregation Inhibitor
C :
convenient
A :
absorbed rapidly
R :
reduces risk of recurrent
vascular events by
up to 32%*
1
E :
effective cardiovascular
protection
†1
DISPRIN CARDIOCARE
®
*32% odds reduction of recurrent vascular events in high risk patients,based on results from 12 clini-
cal studies (n=6776) using aspirin doses of 75-150 mg/day.
1
†Aspirin has been proven to be an effective antithrombotic agent in a variety of vascular disorders,
including transient ischaemic attack and ischaemic stroke,men at high cardiovascular risk,
hypertension,stable and unstable angina,severe carotid artery stenosis,polycythemia vera,acute
myocardial infarction and acute ischaemic stroke.
1
Reference:
1.Patrono C,Baigent C,Hirsch J,
et al
.Antiplatelet drugs:American College of
Chest Physicians evidence-based clinical practice guidelines.
Chest
2008;
133
:199S-233S.
S0 Disprin® Cardiocare 100 mg.Reg no.31/2.8/0071.Each tablet contains 100 mgAspirin.
Reckitt Benckiser Pharmaceuticals (Pty) Ltd,8 Jet Park Road,Elandsfontein,1601.DCC 11/03-3
FHC 314273/23
